No Long COVID Drugs Yet, But Other Treatments Available

Allison Saulino, 46, long COVID advocate, Hilliard, OH.

David Putrino, PhD, director of rehabilitation innovation, Mount Sinai Wellness Technique, New York Town.

Andrew Schamess, MD, professor of internal medication, Ohio State Wexner Medical Center, who runs the Post-COVID Recovery Method.

Daniel Sterman, MD, director, Division of Pulmonary, Critical Care and Sleep Medication, NYU Langone Health and fitness, New York City.

Jennifer Frontera, MD, neurologist, NYU Langone Health.

Journal of Neurological Science: “Mid and Lengthy-Time period Neurological and Neuropsychiatric Manifestations of Write-up-COVID-19 Syndrome: A Meta-Assessment.”

American Academy of Otolaryngology: “Smell Retraining Remedy.”

PLOS Pathogens: “SARS-CoV-2-Certain T-Cells Affiliate with Irritation and Decreased Lung Functionality in Pulmonary Publish-Acute Sequalae of SARS-CoV-2.”

Science Translational Drugs: ”SARS-CoV-2 An infection Makes Serious Pulmonary Epithelial and Immune Cell Dysfunction with Fibrosis in Mice.”

Rheumatic & Musculoskeletal Conditions: “Fibromyalgia: a New Facet of the Publish-COVID-19 Syndrome Spectrum? Success From A Website-Primarily based Study.”

Journal of Thrombosis and Haemostasis: “Persistent Endotheliopathy in the Pathogenesis of Prolonged COVID Syndrome.”

Worldwide Discussion board of Allergy and Rhinology: “Budesonide Irrigation with Olfactory Teaching Enhances Results As opposed with Olfactory Schooling Alone in Individuals with Olfactory Decline.”

Oregon Overall health & Science College: “Clinical Pointers: Extensive COVID-19.”

Sharing is caring!

Facebook Comments

Leave a Reply